Literature DB >> 15241431

Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics.

J H Lee1, R Mayeux, D Mayo, J Mo, V Santana, J Williamson, A Flaquer, A Ciappa, H Rondon, P Estevez, R Lantigua, T Kawarai, A Toulina, M Medrano, M Torres, Y Stern, B Tycko, E Rogaeva, P St George-Hyslop, J A Knowles.   

Abstract

Familial Alzheimer's disease (AD [MIM 104300]) has been a focus of intense investigation, primarily in Caucasian families from Europe and North America families. Although the late-onset form of familial AD, beginning after age 65 years, has been linked to regions on chromosomes 10q and 12p, the specific genetic variants have not yet been consistently identified. Using a unique cohort of families of Caribbean Hispanics ancestry, we screened the genome using 340 markers on 490 family members from 96 families with predominantly late-onset AD. We observed the strongest support for linkage on 18q (LOD=3.14). However, 17 additional markers (chromosomes 1-6, 8, 10, 12, and 14) exceeded a two-point LOD score of 1.0 under the affecteds-only autosomal dominant model or affected sibpair model. As we previously reported the fine-mapping effort on 12p showing modest evidence of linkage, we focused our fine-mapping efforts on two other candidate regions in the current report, namely 10q and 18q. We added 31 family members and eight additional Caribbean Hispanic families to fine map 10q and 18q. With additional microsatellite markers, the evidence for linkage for 18q strengthened near 112 cM, where the two-point LOD score for D18S541 was 3.37 and the highest NPL score in that region was 3.65 (P=0.000177). This narrow region contains a small number of genes expressed in the brain. However, at 10q (134-138 cM), the NPL score decreased from 3.15 (P=0.000486) to 2.1 (P=0.0218), but two broad peaks remained overlapping with previously reported peaks. Our results provide modest support for linkage on 10q and 12p in this cohort of Caribbean Hispanic families with familial Alzheimer's disease, and strong evidence for a new locus on 18q.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241431      PMCID: PMC1578737          DOI: 10.1038/sj.mp.4001538

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  49 in total

1.  Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis.

Authors:  J Pittman; H Andrews; T Tatemichi; B Link; E Struening; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1992-05

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  Relationship estimation in affected sib pair analysis of late-onset diseases.

Authors:  H H Göring; J Ott
Journal:  Eur J Hum Genet       Date:  1997 Mar-Apr       Impact factor: 4.246

5.  Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

Authors:  F Wavrant-DeVrièze; J Pérez-Tur; J C Lambert; B Frigard; F Pasquier; A Delacourte; P Amouyel; J Hardy; M C Chartier-Harlin
Journal:  Neurosci Lett       Date:  1997-05-09       Impact factor: 3.046

6.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results.

Authors:  E Lander; L Kruglyak
Journal:  Nat Genet       Date:  1995-11       Impact factor: 38.330

7.  Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.

Authors:  G Maestre; R Ottman; Y Stern; B Gurland; M Chun; M X Tang; M Shelanski; B Tycko; R Mayeux
Journal:  Ann Neurol       Date:  1995-02       Impact factor: 10.422

8.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

9.  LABMAN and LINKMAN: a data management system specifically designed for genome searches of complex diseases.

Authors:  P Adams
Journal:  Genet Epidemiol       Date:  1994       Impact factor: 2.135

10.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12.

Authors:  M A Pericak-Vance; M P Bass; L H Yamaoka; P C Gaskell; W K Scott; H A Terwedow; M M Menold; P M Conneally; G W Small; J M Vance; A M Saunders; A D Roses; J L Haines
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

View more
  15 in total

1.  Single-nucleotide polymorphism rs498055 on chromosome 10q24 is not associated with Alzheimer disease in two independent family samples.

Authors:  Lars Bertram; Monica Hsiao; Christoph Lange; Deborah Blacker; Rudolph E Tanzi
Journal:  Am J Hum Genet       Date:  2006-07       Impact factor: 11.025

2.  Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Davis Ryman; Yuan Gao; Bruce T Lamb
Journal:  Neurobiol Aging       Date:  2007-04-02       Impact factor: 4.673

3.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.

Authors:  Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop
Journal:  Nat Genet       Date:  2007-01-14       Impact factor: 38.330

4.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.

Authors:  Joseph H Lee; Sandra Barral; Rong Cheng; Inara Chacon; Vincent Santana; Jennifer Williamson; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Yaakov Stern; Benjamin Tycko; Ekaterina Rogaeva; Yosuke Wakutani; Toshitaka Kawarai; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2007-10-17       Impact factor: 2.660

5.  Further examination of the candidate genes in chromosome 12p13 locus for late-onset Alzheimer disease.

Authors:  Joseph H Lee; Rong Cheng; Ekaterina Rogaeva; Yan Meng; Yaakov Stern; Vincent Santana; Rafael Lantigua; Martin Medrano; Ivonne Z Jimenez-Velazquez; Lindsay A Farrer; Peter St George-Hyslop; Richard Mayeux
Journal:  Neurogenetics       Date:  2008-03-14       Impact factor: 2.660

Review 6.  Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biol Psychiatry       Date:  2013-07-25       Impact factor: 13.382

Review 7.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

Review 8.  The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

Authors:  Rita J Guerreiro; Deborah R Gustafson; John Hardy
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

9.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582

10.  Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.

Authors:  Zhijie Xiao; Juan Wang; Weirong Chen; Peng Wang; Houlin Zeng; Weixi Chen
Journal:  Lipids Health Dis       Date:  2012-11-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.